Three Polymorphisms of XRCC1 (Arg194Trp, Arg280His,Arg399Gln) and the Risk of Gliomas: a Meta-analysis

Abstract | PDF | HTML | Order a Reprint

January 01, 2018.

BIOWED January 01, 2018 To read the full article

Metrics: PDF views | HTML views



Figure.1 A flow diagram of the study selection process.

Table.1 Characters of included studies.

Notes: (1) Abbreviation, PCR-RFLP: cleaved amplification polymorphism sequence-tagged sites; PCR-CTPP: polymerase chain reaction with confronting two-pair primers. (2) "~" represents the numbers of male or female was not reported detailly.

Table.2 The genotype distribution of XRCC1 in each study.

Notes: "~" represents the corespondenting polymorphism was not reported.

Table.3 Summary about the meta-analysis on the association between XRCC1 Arg194Trp polymorphism and risk of gliomas.

Table.4 Summary about the meta-analysis on the association between XRCC1 Arg280His polymorphism and risk of gliomas.

Figure.2 Forest plot of Arg399Gln polymorphism in XRCC1 and risk of gliomas in four genetic comparison models.

Table.5 Summary about the meta-analysis on the association between XRCC1 Arg399Gln polymorphism and risk of gliomas.

Figure.3 Funnel plot for the assessment of publication bias. (A) XRCC1 Arg194Trp polymorphism; (B) XRCC1 Arg280His polymorphism; (C) XRCC1 Arg399Gln polymorphism.

Copyright © 2017-2018 Biowed Scientific Publisher,2016-2018 All rights reserved